Dual-color ultrabright AIEgens nanoparticles-based lateral flow immunoassay for simultaneous quantitative detection of serum amyloid A protein and C-reactive protein.

Published 05/19/2026

Research record: Dual-color ultrabright AIEgens nanoparticles-based lateral flow immunoassay for simultaneous quantitative detection of serum amyloid A protein and C-reactive protein.

Published in Anal Chim Acta; first publication date 2026-05-19. PMID 42230014.

This literature update records publication metadata from Europe PMC. Consult the original publication for its methods, findings and limitations.

Read the original publication on PubMed

Talk to a Specialist Browse all insights

Review and references

Source

Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.

Published

2026-05-19

Updated

2026-10-20

Disclaimer

professional use

References